ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 659,06
1,13%
DAX
18 001,60
0,54%
Brent Oil
83,215
-0,50%
Bitcoin
61 587,10
4,17%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PhenomeX Inc (CELL)

  7. PhenomeX Inc (CELL) Actualités

CELL PhenomeX Inc

0,9981
0,00 (0,00%)
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PhenomeX Inc CELL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,9981 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,9981
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/2/202423:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/10/202315:00EDGAR2Form 15-12G - Securities registration termination [Section..
03/10/202321:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202321:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202320:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202323:16EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
02/10/202323:06EDGAR2Form S-8 POS - Securities to be offered to employees in..
02/10/202314:47EDGAR2Form 8-K - Current report
29/9/202314:30EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/9/202314:51PRNUSPhenomeX Announces Opto® Memory B Discovery Human Workflow..
21/9/202314:35PRNUSPhenomeX Announces the Release of SpotLight™ Human Lambda..
20/9/202314:48PRNUSPhenomeX to Participate in Upcoming Cell Biology Conferences
20/9/202312:05EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/9/202315:08PRNUSPhenomeX Unveils Meteor™ Chips For Quantitative Bulk..
05/9/202322:02PRNUSPhenomeX Inc. Announces Commencement of Cash Tender Offer by..
31/8/202322:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28/8/202323:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/8/202323:21EDGAR2Form SC14D9C - Written communication relating to third party..
17/8/202323:28EDGAR2Form SC14D9C - Written communication relating to third party..
17/8/202323:27EDGAR2Form 8-K - Current report
17/8/202315:10EDGAR2Form SC14D9C - Written communication relating to third party..
17/8/202315:09EDGAR2Form 8-K - Current report
17/8/202315:00BWBruker Corporation and PhenomeX Inc. Announce Definitive..
14/8/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:09EDGAR2Form 8-K - Current report
14/8/202322:05PRNUSPhenomeX Reports Second Quarter 2023 Financial Results and..
09/8/202322:25PRNUSPhenomeX to Report Second Quarter 2023 Financial Results on..
07/8/202314:11PRNUSPhenomeX Announces Lifting of the Stay in AbCellera Patent..
28/7/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202300:15EDGAR2Form 144 - Report of proposed sale of securities
07/7/202322:15EDGAR2Form 8-K - Current report
13/6/202315:32PRNUSPhenomeX's Beacon® Technology Enables Early Identification..
05/6/202314:46PRNUSPhenomeX Launches Beacon Quest™ Optofluidic System with..
15/5/202315:01PRNUSPhenomeX Launches Beacon Select™ Optofluidic System with..
11/5/202322:02PRNUSPhenomeX Reports First Quarter 2023 Financial Results
11/5/202315:35PRNUSPhenomeX To Participate in 19th Annual PEGS Boston..

Dernières Valeurs Consultées

NASDAQ
CELL
PhenomeX
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés